Newsroom

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms
  • Dana-Farber Blog

    • Insight Blog screenshot Insight features the latest in cancer care and research news from Dana-Farber.
    • Read the blog 
  • Dana-Farber Facts

    • Dana-Farber 2015 Facts brochureFind statistics on Dana-Farber's patient care, fundraising initiatives and achievements, and phone numbers for patients and families.
    • View Dana-Farber Facts 
  • Dana-Farber View Book

    • Dana-Farber 2011 Viewbook coverThis 24-page magazine gives an overview of Dana-Farber, focusing on its equal investment in research and patient care.
    • View Dana-Farber View Book 
     
  • The Cancer Treatment Revolution

    • The Cancer Treatment Revolution book cover Dr. David Nathan, acclaimed pediatric hematologist and Dana-Farber's president from 1995 – 2000, recounts that history's triumphs and struggles in his book, The Cancer Treatment Revolution.
     

Dana-Farber Spotlight

Sign up to receive Dana-Farber Spotlight, our email newsletter.
View the current issue
Subscribe now
Unsubscribe from mailings

Media Contacts

Ellen Berlin
Director of Media Relations
617-632-4090
ellen_berlin@dfci.harvard.edu 

Molly McHale
Associate Director of Media Relations
617-632-4090
molly_mchale@dfci.harvard.edu 

 

Top News Releases

Ann Partridge, MD, MPH
Kwok-Kin Wong, MD, PhD
Keith Ligon, MD, PhD
  • February 01, 2016
  • Genetic cause identified in rare pediatric brain tumor
  • Researchers found a way of differentiating angiocentric gliomas from other low-grade pediatric brain tumors and developed a pathological test that will help children avoid unnecessary and potentially damaging additional therapies.
Katherine Janeway, MD
  • January 28, 2016
  • Genetic sequencing can help guide treatment in children with solid tumors
  • Clinical genomic sequencing is feasible in pediatric oncology and can be used to recommend therapy or pinpoint diagnosis in children with solid tumors according to research led by Dana-Farber/Boston Children's Cancer and Blood Disorders Center. The findings, published in JAMA Oncology, represent a significant step in making precision medicine available to children with cancer.

Dana Farber In the News

Publications

    Image Alt Text
    Image Alt Text
    Image Alt Text


Content